| Literature DB >> 31813773 |
Dan Lewer1, Wikum Jayatunga2, Robert W Aldridge3, Chantal Edge4, Michael Marmot5, Alistair Story6, Andrew Hayward4.
Abstract
BACKGROUND: Low socioeconomic position is consistently associated with increased risk of premature death. The aim of this study is to measure the aggregate scale of inequality in premature mortality for the whole population of England.Entities:
Mesh:
Year: 2019 PMID: 31813773 PMCID: PMC7098478 DOI: 10.1016/S2468-2667(19)30219-1
Source DB: PubMed Journal: Lancet Public Health
Inequality over time
| Male | 36·1% | 36·7% | 37·3% | 38·1% | 37·0% | 5·5% | |
| Female | 31·6% | 32·7% | 34·2% | 35·5% | 33·4% | 12·3% | |
| Male | 1·73 | 1·60 | 1·46 | 1·34 | 1·53 | –22·5% | |
| Female | 0·97 | 0·91 | 0·86 | 0·82 | 0·89 | –15·5% | |
| Male | |||||||
| Most deprived | 865 | 796 | 725 | 694 | 770 | –19·8% | |
| Least deprived | 331 | 293 | 259 | 239 | 280 | –27·8% | |
| Difference | 534 | 503 | 465 | 455 | 489 | –14·8% | |
| Female | |||||||
| Most deprived | 511 | 478 | 449 | 443 | 470 | –13·3% | |
| Least deprived | 220 | 197 | 176 | 164 | 189 | –25·5% | |
| Difference | 291 | 281 | 272 | 279 | 281 | –4·1% | |
Mortality is adjusted to the European Standard Population 2013. Rates for other deciles are not shown for brevity, and lie monotonically between these values. MASI=mortality attributable to socioeconomic inequality. YLLI=mean premature years of life lost per person.
Change in values from 2003–06 to 2015–18.
Most deprived refers to the most deprived decile of the index of multiple deprivation 2015.
Least deprived refers to the least deprived decile.
Figure 1Mortality attributable to socioeconomic inequality and years lost to inequality in England, 2003–18 by index of multiple deprivation decile
Figure 2Percentage of premature mortality attributable to socioeconomic inequality by sex, deprivation, and age group in England, 2003–18
Values for the least deprived group are zero as this is the reference group.
MASI and YLLI, by major cause of death in England (2003–18)
| Observed | Expected | Excess | MASI (95% CI) | Observed | Expected | Excess | YLLI (%) | ||
|---|---|---|---|---|---|---|---|---|---|
| Cancers | |||||||||
| Breast | 84 301 | 80 613 | 3 688 | 4·4% (2·5–6·2) | 1·4 | 1·4 | 0·0 | 2·0% | |
| Digestive | 271 981 | 219 519 | 52 462 | 19·3% (18·3–20·3) | 3·4 | 2·8 | 0·6 | 17·9% | |
| Female genital | 55 661 | 46 166 | 9495 | 17·1% (14·9–19·3) | 0·8 | 0·7 | 0·1 | 18·5% | |
| Respiratory | 236 968 | 125 885 | 111 083 | 46·9% (46·0–47·7) | 2·7 | 1·4 | 1·3 | 48·1% | |
| Other cancers | 73 354 | 67 936 | 5418 | 7·4% (5·4–9·4) | 1·0 | 1·0 | 0·1 | 5·6% | |
| Lymphoid and haemopoietic | 278 852 | 234 809 | 44 043 | 15·8% (14·8–16·8) | 3·9 | 3·4 | 0·5 | 12·1% | |
| Cardiovascular | |||||||||
| Stroke | 111 210 | 68 383 | 42 827 | 38·5% (37·2–39·8) | 1·4 | 0·8 | 0·6 | 42·6% | |
| Ischaemic heart disease | 335 526 | 183 355 | 152 171 | 45·4% (44·6–46·1) | 4·1 | 2·1 | 2·0 | 48·4% | |
| Other heart disease | 59 333 | 35 861 | 23 472 | 39·6% (37·7–41·4) | 0·9 | 0·6 | 0·4 | 39·5% | |
| Other cardiovascular disease | 97 475 | 59 376 | 38 099 | 39·1% (37·7–40·5) | 1·3 | 0·7 | 0·6 | 43·9% | |
| Nervous system | 85 297 | 68 391 | 16 906 | 19·8% (18·0–21·5) | 1·5 | 1·1 | 0·4 | 25·0% | |
| Respiratory | |||||||||
| COPD | 129 062 | 45 469 | 83 593 | 64·8% (63·8–65·7) | 1·3 | 0·4 | 0·9 | 68·5% | |
| Flu and pneumonia | 57 676 | 28 163 | 29 513 | 51·2% (49·5–52·9) | 0·8 | 0·4 | 0·4 | 53·5% | |
| Other respiratory causes | 43 721 | 26 472 | 17 249 | 39·5% (37·3–41·6) | 0·6 | 0·3 | 0·3 | 44·9% | |
| Digestive | |||||||||
| Liver | 93 505 | 43 344 | 50 161 | 53·6% (52·4–54·9) | 1·9 | 0·8 | 1·1 | 58·6% | |
| Other digestive disease | 69 904 | 36 952 | 32 952 | 47·1% (45·6–48·7) | 1·0 | 0·5 | 0·5 | 51·2% | |
| External | |||||||||
| Accidents | 86 270 | 50 534 | 35 736 | 41·4% (39·8–43·1) | 2·7 | 1·7 | 1·0 | 37·9% | |
| Other external causes | 79 799 | 52 275 | 27 524 | 34·5% (32·7–36·3) | 2·5 | 1·7 | 0·9 | 34·2% | |
| Neonatal | 31 247 | 19 490 | 11 757 | 37·6% (34·6–40·6) | 2·5 | 1·7 | 0·8 | 33·1% | |
| Other | 184 143 | 95 211 | 88 932 | 48·3% (47·3–49·3) | 4·0 | 2·1 | 2·0 | 48·3% | |
| Total | 2 465 285 | 1 588 203 | 877 082 | 35·6% (35·3–35·9) | 39·8 | 25·4 | 14·4 | 36·2% | |
Data are n, % (95% CI), or %. MASI=mortality attributable to socioeconomic inequality. YLLI=years of life lost to inequality. COPD=chronic obstructive pulmonary disease.
Figure 3Inequality in premature mortality in England, 2003–18
Area of circles is proportional to the number of premature deaths. Dark areas represent deaths attributable to socioeconomic inequality. *Diseases of oesophagus, stomach, and duodenum. †Disorders of gallbladder, biliary tract, and pancreas. ‡Diseases of arteries, arterioles, and capillaries.